Redmile as of Dec. 31, 2013
Portfolio Holdings for Redmile
Redmile holds 56 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 6.0 | $49M | 647k | 75.15 | |
| Clovis Oncology | 4.3 | $35M | 572k | 60.27 | |
| Zimmer Holdings (ZBH) | 4.2 | $34M | 368k | 93.19 | |
| Celgene Corporation | 3.8 | $31M | 183k | 168.96 | |
| AstraZeneca (AZN) | 3.7 | $30M | 511k | 59.37 | |
| Actavis | 3.6 | $29M | 172k | 168.00 | |
| Puma Biotechnology (PBYI) | 3.0 | $24M | 231k | 103.53 | |
| Jazz Pharmaceuticals (JAZZ) | 2.9 | $23M | 183k | 126.56 | |
| Incyte Corporation (INCY) | 2.8 | $23M | 449k | 50.63 | |
| Array BioPharma | 2.8 | $22M | 4.5M | 5.01 | |
| Allergan | 2.7 | $22M | 200k | 111.08 | |
| Globus Med Inc cl a (GMED) | 2.7 | $22M | 1.1M | 20.18 | |
| Bristol Myers Squibb (BMY) | 2.6 | $21M | 401k | 53.15 | |
| HeartWare International | 2.6 | $21M | 222k | 93.96 | |
| Kythera Biopharmaceuticals I | 2.6 | $21M | 558k | 37.25 | |
| Amicus Therapeutics (FOLD) | 2.5 | $20M | 8.6M | 2.35 | |
| Hca Holdings (HCA) | 2.5 | $20M | 419k | 47.71 | |
| Tenet Healthcare Corporation (THC) | 2.4 | $19M | 461k | 42.12 | |
| Oxford Immunotec Global | 2.3 | $18M | 947k | 19.38 | |
| Intercept Pharmaceuticals In | 2.2 | $18M | 266k | 68.28 | |
| Receptos | 2.2 | $18M | 625k | 28.99 | |
| NuVasive | 2.2 | $18M | 551k | 32.33 | |
| Universal Health Services (UHS) | 2.1 | $17M | 205k | 81.26 | |
| Pfizer (PFE) | 2.0 | $16M | 536k | 30.63 | |
| Accuray Incorporated (ARAY) | 1.9 | $15M | 1.7M | 8.71 | |
| Gw Pharmaceuticals Plc ads | 1.9 | $15M | 360k | 41.54 | |
| Merck & Co Inc New option | 1.7 | $14M | 283k | 50.05 | |
| Forest Laboratories | 1.7 | $14M | 228k | 60.03 | |
| Insulet Corporation (PODD) | 1.7 | $14M | 363k | 37.10 | |
| Cerus Corporation (CERS) | 1.6 | $13M | 2.1M | 6.45 | |
| St. Jude Medical | 1.6 | $13M | 213k | 61.95 | |
| Nanostring Technologies (NSTGQ) | 1.6 | $13M | 755k | 17.24 | |
| Healthways | 1.6 | $13M | 846k | 15.35 | |
| Chimerix (CMRX) | 1.4 | $11M | 746k | 15.11 | |
| Ophthotech | 1.3 | $10M | 317k | 32.35 | |
| Celldex Therapeutics | 1.2 | $9.6M | 398k | 24.21 | |
| VCA Antech | 1.2 | $9.6M | 306k | 31.36 | |
| Tornier Nv | 1.1 | $9.2M | 488k | 18.79 | |
| Illumina (ILMN) | 1.1 | $9.0M | 82k | 110.62 | |
| Sirona Dental Systems | 1.1 | $8.7M | 124k | 70.20 | |
| Amarin Corporation | 1.0 | $7.9M | 4.0M | 1.97 | |
| NxStage Medical | 0.8 | $6.9M | 691k | 10.00 | |
| BioSpecifics Technologies | 0.8 | $6.2M | 286k | 21.67 | |
| Endologix | 0.7 | $5.5M | 316k | 17.44 | |
| XOMA CORP Common equity shares | 0.7 | $5.3M | 781k | 6.73 | |
| Ambit Bioscience | 0.7 | $5.3M | 546k | 9.64 | |
| Vocera Communications | 0.6 | $4.4M | 284k | 15.61 | |
| Foundation Medicine | 0.3 | $2.6M | 110k | 23.82 | |
| Model N (MODN) | 0.1 | $1.1M | 91k | 11.80 | |
| Market Vectors Etf Tr pharmaceutical | 0.0 | $345k | 6.5k | 53.08 | |
| Regeneron Pharmaceuticals (REGN) | 0.0 | $275k | 1.0k | 275.00 | |
| iShares Dow Jones US Health Care (IHF) | 0.0 | $280k | 3.0k | 93.33 | |
| Prothena (PRTA) | 0.0 | $241k | 9.1k | 26.48 | |
| Dyax | 0.0 | $188k | 25k | 7.52 | |
| Sunesis Pharmaceuticals | 0.0 | $166k | 35k | 4.74 | |
| Merck & Co (MRK) | 0.0 | $120k | 2.4k | 50.00 |
